Item 7. Management’s Discussion and Analysis
ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS
OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
References
to the “Company,” “Starry Sea,” “our,” “us” or “we” refer to Starry Sea Acquisition
Corp. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction
with our audited financial statements and the notes related thereto which are included in “Item 8. Financial Statements and Supplementary
Data” of this Annual Report on Form 10-K. Certain information contained in the discussion and analysis set forth below includes
forward-looking statements. Our actual results may differ materially from those anticipated in these forward-looking statements as a result
of many factors, including those set forth under “Cautionary Note Regarding Forward-Looking Statements,” “Item 1A. Risk
Factors” and elsewhere in this Annual Report on Form 10-K.
Cautionary
Note Regarding Forward-Looking Statements
This
Annual Report on Form 10-K includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Exchange Act. We have based these forward-looking statements on our current expectations and projections
about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that
may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels
of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking
statements by terminology such as “may,” “should,” “could,” “would,” “expect,”
“plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of
such terms or other similar expressions. Factors that might cause or contribute to such a discrepancy include, but are not limited to,
those described in our other U.S. Securities and Exchange Commission (“SEC”) filings.
Overview
We
are a blank check company incorporated in the Cayman Islands on December 5, 2024 as an exempted company with limited liability (meaning
our public shareholders have no liability, as shareholders of the company, for the liabilities of the company over and above the amount
paid for their shares) to serve as a vehicle to effect a merger, share exchange, asset acquisition, share purchase, recapitalization,
reorganization or similar business combination with one or more target businesses. Our efforts to identify a prospective target business
will not be limited to a particular industry or geographic location. We intend to utilize cash derived from the proceeds of this offering,
our securities, debt or a combination of cash, securities and debt, in effecting a business combination.
We
expect to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business
Combination will be successful.
Results
of Operations
We
have neither engaged in any operations nor generated any revenues to date. Our only activities since inception have been organizational
activities and those necessary to prepare for the initial public offering and subsequent to our initial public offering, identifying a
target company for an initial business combination. Our only activities since inception have been organizational activities and those
necessary to prepare for the Initial Public Offering and the initial business combination. Following the initial public offering, we will
not generate any operating revenue until after completion of our initial business combination. We generated non-operating income in the
form of interest income on investments held in trust and cash.
The
operating costs incurred in the period from January 18, 2024 (inception) to December 31, 2025 consist primarily of approximately
$610,156 of professional fees, insurance, costs and fees associated with our financial reporting, listing and other public company costs.
We expect to incur increased expenses as a result of being a public company (for legal, financial reporting, accounting, and auditing
compliance), as well as for due diligence expenses related to our initial business combination.
For
the fiscal year ended December 31, 2025, we had net income of $320,643, which consisted of interest earned on cash held in the Trust
Account of $863,257, partially offset by formation and operating costs of $542,614.
For
the period from December 5, 2024 (inception) to December 31, 2024, we had a net loss of $6,974, which consisted of formation
and operating costs of $6,974.
72
Recent
Developments
On
September 29, 2025, the Company entered into a letter of intent (the “Letter of Intent”) with Forever Young International
Limited., a Cayman Islands exempted company and a health industry operator providing comprehensive management and support service solutions
for medical institutions in China (“Forever Young”), for a proposed business combination (the “Proposed Business Combination”).
Pursuant to the Letter of Intent, the parties have entered into a period of exclusivity in order to negotiate the Company’s acquisition
of Forever Young wherein, among other things, the Company agreed not to solicit, negotiate, conduct or commit to conduct any alternative
business combination proposal. The Letter of Intent contemplates that the pre-money equity value ascribed to Forever Young will be in
the range of approximately $750 million to $900 million, subject to confirmatory due diligence by both parties. The consideration is expected
to be comprised of rollover equity to Forever Young’s shareholders in the form of ordinary shares of the post-closing publicly-listed
entity, each valued at $10 per share.
Liquidity
and Capital Resources
Our
liquidity needs prior to the consummation of the IPO had been satisfied through a payment from the Sponsor of $25,000 for the Founder
Shares and the loan under an unsecured promissory note from the Sponsor of $500,000. In connection with the closing of our IPO, the approximately
$387,484 drawn down under the unsecured promissory note was repaid in full.
On August 11, 2025,
the Company consummated its IPO of 5,000,000 Units, at an offering price of $10.00 per Unit, generating total gross proceeds of $50,000,000.
In connection with the IPO, the underwriter was granted the underwriter a 45-day option to purchase up to an additional 750,000 Units
at the Initial Public Offering price to cover over-allotments, if any. On August 11, 2025, the over-allotment option was exercised,
generating gross proceeds of $7,500,000 and deposited into the Trust Account.
Simultaneously
with the consummation of the IPO and exercise of over-allotment option, we consummated the private placement (“Private Placement”)
of 247,121 Initial Private Placement Units to the Sponsor, at a price of $10.00 per Initial Private Placement Unit, generating total proceeds
of $2,471,210. Each Private Placement Unit consists of one ordinary share and one right to receive one-sixth (1/6 th ) of one
ordinary share. The Private Placement was conducted as a non-public transaction and, as a transaction by an issuer not involving a public
offering, is exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”), in reliance upon
Section 4(a)(2) of the Securities Act.
Upon
the closing of the IPO and the private placement, a total of $57,500,000 was placed in a trust account (the “Trust Account”)
maintained by Continental Stock Transfer & Trust Company as a trustee and will be invested only in U.S. government treasury bills
with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company
Act of 1940, as amended (the “Investment Company Act”), and that invest only in direct U.S. government treasury obligations.
Except for the withdrawal of interest earned on the amounts in the trust account to fund the Company’s taxes, if any, or upon the
redemption by public shareholders of Ordinary Shares in connection with certain amendments to the Company’s amended and restated
memorandum and articles of association, none of the funds held in the trust account will be released until the completion of the Company’s
initial business combination or the redemption by the Company of 100% of the outstanding Ordinary Shares issued by the Company in the
Initial Public Offering if the Company does not consummate an initial business combination within 15 months from August 7, 2025,
the effective date of the Registration Statement.
We
intend to use substantially all of the net proceeds of the IPO and the private placement, including the funds held in the Trust Account,
in connection with our initial business combination and to pay our expenses relating thereto. To the extent that our capital stock is
used in whole or in part as consideration to effect our initial business combination, the remaining proceeds held in the Trust Account
as well as any other net proceeds not expended will be used as working capital to finance the operations of the target business. Such
working capital funds could be used in a variety of ways including continuing or expanding the target business’ operations, for
strategic acquisitions and for marketing, research and development of existing or new products. Such funds could also be used to repay
any operating expenses or finders’ fees which we had incurred prior to the completion of our initial business combination if the
funds available to us outside of the Trust Account were insufficient to cover such expenses.
73
We
will use funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on
prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives
or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete
a business combination. We also have ongoing professional and other costs to maintain our reporting, listing, compliance and administrative
requirements of being a publicly traded company. In addition, we could use a portion of the funds not being placed in trust to pay commitment
fees for financing, fees to consultants to assist us with our search for a target business or as a down payment or to fund a “no-shop”
provision, a provision designed to keep target businesses from “shopping” around for transactions with other companies or
investors on terms more favorable to such target businesses) with respect to a particular proposed business combination, although we do
not have any current intention to do so. If we entered into an agreement where we paid for the right to receive exclusivity from a target
business, the amount that would be used as a down payment or to fund a “no-shop” provision would be determined based on the
terms of the specific business combination and the amount of our available funds at the time. Our forfeiture of such funds (whether as
a result of our breach or otherwise) could result in our not having sufficient funds to continue searching for, or conducting due diligence
with respect to, prospective target businesses.
We
currently believes that it does not need additional capital to satisfy its liquidity needs beyond the net proceeds from the consummation
of the IPO and the proceeds held outside of the Trust Account for paying existing accounts payable, identifying and evaluating prospective
business combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting
the target business to merge with or acquire, and structuring, negotiating and consummating the Initial Business Combination. However,
if our estimates of the costs of identifying a target business, undertaking in-depth due diligence and negotiating an initial business
combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior
to our initial business combination. Moreover, we may need to obtain additional financing either to complete our initial business combination
or because we become obligated to redeem a significant number of our public shares upon completion of our initial business combination,
in which case we may issue additional securities or incur debt in connection with such business combination. Our sponsor, an affiliate
of our sponsor or our officers and directors may, but none of them is obligated to, loan us funds as may be required to fund our working
capital requirements. If we complete our initial business combination, we will repay such loaned amounts out of the proceeds of the trust
account released to us. In the event that our initial business combination does not close, we may use a portion of the working capital
held outside the trust account to repay such loaned amounts but no proceeds from our trust account would be used for such repayment. Except
for the foregoing, the terms of such loans, if any, have not been determined and no written agreements exist with respect to such loans.
We do not expect to seek loans from parties other than our sponsor, an affiliate of our sponsor or our officers and directors, if any,
as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to
funds in our trust account. In addition, if we raise additional funds through equity or convertible debt issuances, our public shareholders
may suffer significant dilution, and these securities could have rights that rank senior to our public shares. If we raise additional
funds through the incurrence of indebtedness, such indebtedness would have rights that are senior to our equity securities and could contain
covenants that restrict our operations.
As
of December 31, 2025, the Company had $112,134 in cash and cash equivalents held outside of the Trust Account and working capital
of $379,066. For the fiscal year ended December 31, 2025, we had net income of $320,643, which consisted of interest earned on cash
held in the Trust Account of $863,257, partially offset by formation and operating costs of $542,614. For the period from December 5,
2024 (inception) to December 31, 2024, we had a net loss of $6,974, which consisted of formation and operating costs of $6,974. The
Company has incurred and expects to continue to incur significant professional costs to remain as a publicly traded company and to incur
significant transaction costs in pursuit of the consummation of a Business Combination.
Off-Balance
Sheet Financing Arrangements
We
have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of December 31, 2025. We
do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to
as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have
not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments
of other entities, or purchased any non-financial assets.
74
Contractual
Obligations
We
do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement
to pay the Sponsor a monthly fee of $10,000 for certain general and administrative services, including office space, utilities and administrative
services, provided to us. We began incurring these fees on August 11, 2025 and will continue to incur these fees monthly until the
earlier of the completion of a Business Combination or the Company’s liquidation.
Registration
Rights
The
holders of the Founder Shares and Private Units (and their underlying securities) will be entitled to registration rights pursuant to
a registration rights agreement to be signed prior to or on the effective date of the Proposed Public Offering, requiring the Company
to register such securities for resale. The holders of these securities are entitled to make up to three demands, excluding short form
demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights
with respect to registration statements filed subsequent to the completion of the initial business combination and rights to require the
Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The Company will bear the expenses
incurred in connection with the filing of any such registration statements.
Underwriting
Agreement
The underwriters were entitled
to a cash underwriting discount of 2% of the gross proceeds of the Initial Public Offering, or $1,000,000 (or $1,150,000 if the over-allotment
option is exercised in full). Additionally, the Company issued the underwriters 3.5% of the gross proceeds of the IPO as underwriting
discounts and commissions in the form the Company’s shares at a price of $10.00 per ordinary share, resulting in the issuance of
201,250 shares, as the underwriter’s overallotment option was exercised in full upon the consummation of the IPO.
Critical
Accounting Estimates
Basis
of Presentation
The
accompanying audited financial statements are presented in conformity with accounting principles generally accepted in the United States
of America (“U.S. GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”).
The accompanying audited financial statements as of December 31, 2025 has been prepared in accordance with U.S. GAAP and the rules
of the SEC.
Emerging
Growth Company
The
Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart
Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting
requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being
required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley
Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from
the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments
not previously approved.
Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not
have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards.
The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply
to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended
transition period which means that when a standard is issued or revised and it has different application dates for public or private companies,
the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised
standard. This may make comparison of the Company’s financial statements with another public company that is neither an emerging
growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because
of the potential differences in accounting standards used.
75
Ordinary
Shares Subject to Possible Redemption
All
of the 5,750,000 ordinary shares sold as part of the Units in the IPO contain a redemption feature which allows for the redemption
of such public shares in connection with the Company’s liquidation, if there is a shareholder vote or tender offer in connection
with the Business Combination and in connection with certain amendments to the Company’s amended and restated certificate of incorporation.
The
Company accounted for its ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing
Liabilities from Equity” (ASC 480). Ordinary shares subject to mandatory redemption (if any) were classified as a liability instrument
and will be measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that features redemption rights
that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the
Company’s control) were classified as temporary equity. At all other times, ordinary shares were classified as stockholders’
equity. In accordance with ASC 480-10-S99, the Company classified the ordinary shares subject to redemption outside of permanent equity
as the redemption provisions are not solely within the control of the Company.
Given
that the 5,750,000 ordinary shares sold as part of the units in the IPO were issued with other freestanding instruments (i.e.,
rights), the initial carrying value of ordinary shares classified as temporary equity has been allocated to the proceeds determined in
accordance with ASC 470-20. If it is probable that the equity instrument will become redeemable, the Company has the option to either
(i) accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that
the instrument will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the redemption
value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting
period. The Company has elected to recognize the changes in redemption value as a deemed dividend and charges against retained earnings
or, in the absence of retained earnings, by charges against additional paid-in capital, over an expected 15 months from August 7,
2025, the effective date of the Registration Statement, or during any extension period.
Use
of Estimates
In
preparing these audited financial statements in conformity with U.S. GAAP, the Company’s management makes estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the audited
financial statements and the reported expenses during the reporting period.
Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the audited financial statements, which management considered
in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results
could differ significantly from those estimates.
Income
Taxes
The
Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax
assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements
carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using
enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or
settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included
the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.
There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations,
income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements.
76
Earnings
(Loss) Per Ordinary Share
ASC
Topic 820 “Fair Value Measurements and Disclosures” defines fair value, the methods used to measure fair value and the expanded
disclosures about fair value measurements. Fair value is the price that would be received to sell an asset or paid to transfer a liability
in an orderly transaction between the buyer and the seller at the measurement date. In determining fair value, the valuation techniques
consistent with the market approach, income approach and cost approach shall be used to measure fair value. ASC Topic 820 establishes
a fair value hierarchy for inputs, which represents the assumptions used by the buyer and seller in pricing the asset or liability. These
inputs are further defined as observable and unobservable inputs. Observable inputs are those that buyers and sellers would use in pricing
the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs reflect the Company’s
assumptions about the inputs that the buyer and seller would use in pricing the asset or liability developed based on the best information
available in the circumstances.
The
fair value hierarchy is categorized into three levels based on the inputs as follows:
●
Level
1 - Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability
to access. Valuation adjustments and block discounts are not being applied. Since valuations are based on quoted prices that are readily
and regularly available in an active market, valuation of these securities does not entail a significant degree of judgment.
●
Level
2 - Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are
not active for identical or similar assets, (iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that are
derived principally from or corroborated by market through correlation or other means.
●
Level
3 - Valuations based on inputs that are unobservable and significant to the overall fair value measurement.
The
fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820 approximates the
carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature. The carrying amounts reported
in the balance sheet for cash and cash equivalents, marketable securities held in trust account, accounts payable and accrued expenses
and due to related party each qualify as financial instruments and are a reasonable estimate of their fair values because of the short
period between the origination of such instruments and their expected realization and their current market rate of interest.
Recent
Accounting Standards
Management
does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a
material effect on the Company’s audited financial statement.
JOBS
Act
We are an “emerging
growth company” and, under the JOBS Act, are allowed to comply with new or revised accounting pronouncements based on the effective
date for private (not publicly traded) companies. We have elected to delay the adoption of new or revised accounting standards, and as
a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required
for non-emerging growth companies. As such, our financial statements may not be comparable to companies that comply with public company
effective dates.
Additionally,
we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject
to certain conditions set forth in the JOBS Act, if, as an “emerging growth company”, we choose to rely on such exemptions
we may not be required to, among other things, (1) provide an independent registered public accounting firm’s attestation report
on our system of internal controls over financial reporting pursuant to Section 404, (2) provide all of the compensation disclosure
that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (3)
comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor’s
report providing additional information about the audit and the financial statements (auditor discussion and analysis), and (4) disclose
certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of
the CEO’s compensation to median employee compensation. These exemptions will apply for a period of five years following the completion
of this offering or until we are no longer an “emerging growth company,” whichever is earlier.
77
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.